PMV Pharmaceuticals, Inc.
PMVP
$1.57
$0.010.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.42M | 4.31M | 4.48M | 4.12M | 5.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.24M | 22.52M | 22.88M | 21.56M | 18.55M |
| Operating Income | -19.24M | -22.52M | -22.88M | -21.56M | -18.55M |
| Income Before Tax | -18.01M | -21.07M | -21.21M | -19.63M | -23.00M |
| Income Tax Expenses | 26.00K | -6.00K | 5.00K | -2.20M | 0.00 |
| Earnings from Continuing Operations | -18.04M | -21.06M | -21.21M | -17.44M | -23.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.04M | -21.06M | -21.21M | -17.44M | -23.00M |
| EBIT | -19.24M | -22.52M | -22.88M | -21.56M | -18.55M |
| EBITDA | -19.21M | -22.49M | -22.85M | -21.53M | -18.51M |
| EPS Basic | -0.34 | -0.40 | -0.41 | -0.34 | -0.44 |
| Normalized Basic EPS | -0.21 | -0.25 | -0.25 | -0.24 | -0.20 |
| EPS Diluted | -0.34 | -0.40 | -0.41 | -0.34 | -0.44 |
| Normalized Diluted EPS | -0.21 | -0.25 | -0.25 | -0.24 | -0.20 |
| Average Basic Shares Outstanding | 53.20M | 52.99M | 52.01M | 51.95M | 51.82M |
| Average Diluted Shares Outstanding | 53.20M | 52.99M | 52.01M | 51.95M | 51.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |